心脏移植市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00012146
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 149
Buy Now

【研究报告】心脏移植市场规模预计将从2022年的154.7279亿美元增长到2030年的354.7084亿美元;预计 2022 年至 2030 年市场复合年增长率为 10.9%。
市场洞察和分析师观点:
目标疾病发病率的增加和老年人口的增长是推动心脏移植市场发展的关键因素。然而,高昂的手术费用阻碍了市场的增长。在美国,2020 年有近 3,499 人接受了心脏移植手术。2022 年 9 月发布的《NHS 血液与移植》《2021-2022 年心胸器官移植》年度报告的数据表明,2021 年约有 145 例成人进行了心脏移植手术。 2022 年在英国。
在心脏移植市场运营的公司正专注于合作、扩张、协议、伙伴关系和新产品发布,这有助于他们提高销售额、扩大地理覆盖范围并增强满足客户需求的能力比现有的客户群更大。 2023 年 4 月,Terumo Aortic 宣布在北美植入第一个新型定制混合装置 Thoracoflo,该装置用于使用比传统开放手术修复侵入性较小的手术技术来治疗胸腹主动脉疾病患者。
增长驱动力:
新兴国家医疗保健能力的提高和患者数量的增加为心脏移植市场创造了机会
印度、中国、阿根廷、巴西、阿联酋和南非等新兴国家预计将为心脏移植提供重大增长机会移植市场参与者的增长主要是由于蓬勃发展的研发环境、不断增加的患者数量、不断提高的心血管疾病(CVD)意识、改善的医疗基础设施、迅速增长的可支配收入以及与发达经济体相比相对宽松的政策。根据世界经济论坛的数据,截至 2017 年,俄罗斯、中国、巴西、印度和南非是全球增长最快的经济体,它们合计占全球卫生支出总额的三分之一。
根据世界银行数据显示,2018 年至 2019 年,印度和中国的医疗保健支出分别增长了 3.01% 和 5.35%。根据印度品牌资产基金会的数据,2020 年印度医疗保健行业价值 2800 亿美元,同比增长约 71%医院的收入贡献,这表明该国医疗保健行业的显着改善。在中国,私立医院的数量从2011年到2017年翻了一番,达到16,900家。私立医院约占全国医院总数的57%。随着医疗保健支出的不断增长和目标患者人数的增加,发展中市场的外科中心和医院的数量将继续增长。因此,发展中经济体医疗保健设施的发展以及医院数量的流动将反过来导致未来几年心脏移植手术数量的增加,为心脏移植市场参与者创造利润丰厚的机会。
战略见解
报告细分和范围:
“心脏移植市场”根据手术类型、类型和最终用户进行细分。根据手术类型,市场分为原位心脏移植和异位心脏移植。原位心脏移植细分市场将在 2022 年占据更大的市场份额,预计在预测期内(2022-2030 年)复合年增长率将达到 11.1%。心脏移植市场根据类型分为供体活体心脏和人造心脏。 2022 年,供体活体心脏细分市场占据更大的市场份额。预计人工心脏细分市场在预测期内的复合年增长率将达到 11.6%。按最终用户划分,心脏移植市场分为医院、心脏中心等。医院细分市场在 2022 年占据最大的市场份额,预计 2022 年至 2030 年复合年增长率最高,达到 11.2%。
细分市场分析:
心脏移植市场按手术类型细分为原位心脏移植和异位心脏移植。原位心脏移植细分市场将在 2022 年占据更大的市场份额,预计在预测期内复合年增长率将达到 11.1%。原位心脏移植是最常用的技术。在原位方法中,受体的心脏被移除,并使用捐赠者的心脏将其恢复到正确的解剖位置。捐献者的心脏取出后,将被保存并包装运输,必须在4-5小时内移植到受体体内。在进行心脏移植时,对接受者进行全身麻醉,并安排在旁路机上为血液充氧。
心脏移植市场,按手术类型 - 2022 年和 2030 年
心脏移植市场,按类型,分为供体活体心脏和人造心脏。 2022 年,供体活体心脏细分市场占据更大的市场份额。然而,预计人工心脏细分市场在预测期内的复合年增长率将达到 11.6%。活体移植是一种从死者身上取出心脏并将其植入另一个心脏不再正常运作的人体内的手术程序。近年来,由于对移植器官的需求不断增长以及死者心脏(通过自愿捐赠获得)的短缺,活体器官捐赠的受欢迎程度显着增加。大多数捐赠者在确定脑死亡的测试后被宣布死亡。尽管他们因无法自行呼吸而需要使用呼吸机,但他们的心脏仍在继续跳动。传统上,过去 40 年来所有移植的心脏均来自活体捐赠者。
心脏移植市场按最终用户划分为医院、心脏中心等。医院细分市场在 2022 年占据了相当大的市场份额,预计在预测期内复合年增长率将达到 11.2%。医院是大型实体,在一个组织中拥有多个可用设施。医院还提供各种诊断和治疗设施,这些设施可以根据保险索赔进行报销。他们聘请各种医生、专家和其他医疗保健专业人员来提供更好的医疗保健服务。所有 CVD 都可以在医院进行治疗,并且医院提供更好的护理服务。
传统 CVD 危险因素(例如糖尿病、高血压、血脂异常)的高患病率可能与心脏移植手术的需求不断增加有关。 2020年,全球进行了近8,200例心脏移植手术,其中3,658例在美国进行。心脏移植是一项高度复杂的手术,因此这些手术是在设备最完善的医院进行的。美国有 6,000 多家医院,只有不到 150 家医院可以进行心脏移植手术。通过医院工作人员的医疗保健专业人员的适当后续护理,存活率很高。预计这将推动预测期内的市场增长。
区域分析:
根据地理位置,全球心脏移植市场分为北美、欧洲、亚太地区、南美洲和中美洲以及中东地区东非。 2022年,北美在全球心脏移植市场规模中贡献最大份额。亚太地区预计 2022 年至 2030 年复合年增长率最高。该地区市场的增长归因于人们对器官捐赠重要性认识的提高以及社交媒体营销的增加,以说服人们对器官捐赠持积极态度。此外,改善医疗基础设施和增加投资以提高制造能力预计将在预测期内推动亚太地区心脏移植市场的发展。
北美的心脏移植市场进一步分为美国、加拿大和墨西哥。该地区的市场增长可归因于老年人口的激增、心血管疾病的患病率以及心力衰竭病例的增加。慢性肾脏病发病率的增加和老年人口的增加是影响美国心脏移植市场增长的关键因素。根据美国心脏协会提供的数据,美国每年新增约 100 万心力衰竭病例,预计到 2030 年将有超过 800 万人患有心力衰竭。根据健康研究资助组织的数据, 2021 年,美国约有 555,000 人被诊断出患有早期心力衰竭。心血管疾病通常会导致心力衰竭或晚期心脏病,从而增加了对心脏移植的需求。
美国食品和药物管理局 (FDA)越来越多地批准各种心脏移植手术和产品。此外,大公司的存在也有利于该国的市场。 2022 年 4 月,TransMedics Group, Inc. 的 OCS Heart 获得 FDA 上市前批准。
此外,根据加拿大健康信息研究所的最新数据,2021 年加拿大进行了 2,782 例器官移植手术。其中 78%移植物来自已故捐赠者,21% 使用活体捐赠者器官。心脏病是影响心脏和血管的各种疾病的总称。心血管疾病对加拿大人的健康有重大影响。根据加拿大健康信息研究所的数据,约有 240 万加拿大人患有心脏病。加拿大心血管协会表示,约有 75 万加拿大人患有心力衰竭,而超过 10 万加拿大人被诊断患有心力衰竭。根据加拿大心脏和中风基金会进行的一项新的心脏和中风民意调查,约三分之一的加拿大人患有心力衰竭。加拿大健康信息研究所表示,2022年加拿大总共进行了2,936例器官移植;其中,5% 是心脏移植手术。
此外,到 2030 年,加拿大与心力衰竭相关的医疗费用预计每年将达到 28 亿美元。年龄,加上糖尿病、高血压和潜在疾病的患病率不断增加心脏病,是心力衰竭的主要危险因素。因此,心力衰竭成本负担的增加和心血管疾病患病率的增加正在刺激加拿大对心脏移植的需求。
行业发展和未来机遇:
领先企业的各种战略发展心脏移植市场如下:
2022年1月,BioVentrix收购了MateraCor Inc及其主导产品。 MateraCor, Inc. 使用基于藻酸盐的可注射水凝胶来阻止心力衰竭的进展并逆转它。 2021 年 9 月,SynCardia Systems LLC 被总部位于加利福尼亚州的风险投资公司 Hunniwell Lake Ventures, LLC 收购。通过此次收购,SynCardia 现在获得了在国内和国际市场持续扩张和取得成功的运营和财务手段。得益于这笔资金,该公司能够继续创造尖端医疗设备并探索新的适应症。 2021 年 3 月,Berlin Heart 凭借体外脉动 EXCOR 心室辅助提供机械循环支持的创新流出插管获得了 CE 标志设备及其首次植入患者体内。 EXCOR 移植插管将血泵的流出侧连接到升主动脉以提供左心室支持,或连接到肺动脉以提供右心室支持。 2023 年 3 月,BiVACOR Inc 旗下 Cormorant 资产管理公司和 OneVentures 通过 OneVentures Healthcare Fund III 资助该公司资本为1800万美元。这些资金将帮助该公司聘请重要的高管,并支持其正在进行的研发以及人体试验的早期可行性研究。利用这笔财政援助,该公司将聘请研发专业人员和最高管理层等重要职位的候选人,作为其业务规模扩大一倍的努力的一部分。 BiVACOR Inc 还希望在 2023 年底之前首次在人类受试者中对其全人工心脏进行早期可行性研究。竞争格局和主要公司:
Terumo Corp、LivaNova Plc、Jarvik Heart Inc、BiVACOR Inc 、Evaheart Inc、Berlin Heart GmbH、BioVentrix、SynCardia Systems LLC、Calon Cardio-Technology Ltd 和 Abbott Laboratories 是心脏移植市场上的知名公司。这些公司专注于新技术、升级现有产品和地域扩张,以满足全球不断增长的消费者需求。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is heart transplant?

Patients with refractory acute and chronic heart failure get heart transplantation. Although a heterotropic transplant has been described and carried out, the most widely used approach is an orthotopic heart transplant. Patients with debilitating symptoms despite receiving the best medical care possible or those with refractory arrhythmias despite medication and electrophysiological techniques are the main candidates for transplant in chronic heart failure. A heart transplant is recommended for acute heart failure that is resistant to inotropes and mechanical circulatory support.

What are the driving factors for the heart transplant market across the globe?

The factors that are driving growth of the market are increasing target disease incidence and growing geriatric population.

Who are the major players in the heart transplant market?

The heart transplant market majorly consists of the players such as Terumo Corp, Evaheart Inc, Abbott Laboratories, SynCardia, Systems LLC, BiVACOR Inc, BioVentrix Inc, Berlin Heart GmbH, LivaNova Plc, Jarvik Heart Inc, and Calon Cardio-Technology Ltd among others.

Which country is dominated the heart transplant market?

US holds the largest market share in heart transplant market. The increasing incidences of chronic kidney diseases and the rising geriatric population are the key factors contributing to the heart transplant market growth in the US. According to data provided by the American Heart Association Inc., ~1 million new heart failure cases are registered annually in the US, and more than 8 million people are estimated to suffer from heart failure by 2030.

Which surgery type segment is dominating the heart transplant market?

The heart transplant market, based on surgery type, is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. In 2022, the orthotopic heart transplantation segment held the largest share of the market. Moreover, the same segment is expected to record higher CAGR during 2022-2030.

Which type segment is dominating the heart transplant market?

The heart transplant market, based on type, is segmented into donor live heart and artificial heart. In 2022, the donor live heart segment held a larger share of the market. However, the artificial heart segment is anticipated to record a higher CAGR during 2022-2030.

Which end user segment is dominating the heart transplant market?

The heart transplant devices market, based on end user, classified into hospitals, cardiac centers, and others. In 2022, the hospitals segment held the largest share of the market. In addition, the same segment is also expected to record the highest CAGR during 2022-2030.

Which region is the fastest growing the heart transplant market?

Asia Pacific is expected to be the fastest growing region in the heart transplant market. The projected growth of the market in the coming years is attributed to the the rise in healthcare awareness of the importance of organ donation and a surge in social media marketing to encourage a positive attitude toward organ donation. Additionally, advancing healthcare infrastructure and increasing investments to boost manufacturing capacities are projected to drive the Asia Pacific heart transplant market.

The List of Companies - Heart Transplant Market

  1. Terumo Corp
  2. Evaheart Inc  
  3. Abbott Laboratories
  4. SynCardia Systems LLC  
  5. BiVACOR Inc  
  6. BioVentrix Inc
  7. Berlin Heart GmbH
  8. LivaNova Plc  
  9. Jarvik Heart Inc
  10. Calon Cardio-Technology Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports